Category: Smith & Nephew
Here's a look at some of the top legal news stories for medical device companies this week.
Smith & Nephew agrees to pay $12 million to settle a stockholder lawsuit filed to block its $1.7 billion buyout of ArthroCare.
Here's a look at some of the top Wall Street stories for medical device companies this week.
, American College of Cardiology
, Arterial Remodeling Technologies
, Baxter International
, Edwards Lifesciences
, K-C Health Care
, Kimberly-Clark Worldwide Inc.
, Smith & Nephew
, Terumo Corp.
, Urologix Inc.
, Abbott Laboratories
Shares of Smith & Nephew gain on an analyst's speculation that the British medical products conglomerate is ripe for a spinout.
Smith & Nephew inks a deal to integrate OrthoSensor's VeriSense knee implant placement technology with its Journey II and Legion knee implants.
Smith & Nephew introduces its Polarstem cementless total hip replacement stem to the American market.
Smith & Nephew (FTSE:SN, NYSE:SNN) said it's launching its Polarstem cementless hip stem in the United States for total hip replacement procedures.
ArthroCare creates a $15 million fund to transition its employees through the pending $1.7 billion acquisition by Smith & Nephew.